Substance Abuse Treatment

Global Substance Abuse Treatment Market to Reach US$20.8 Billion by 2030

The global market for Substance Abuse Treatment estimated at US$13.7 Billion in the year 2024, is expected to reach US$20.8 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Alcohol Addiction Treatment segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 6.6% CAGR

The Substance Abuse Treatment market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Substance Abuse Treatment Market - Key Trends and Drivers Summarized

Why Is Substance Abuse Treatment Gaining Importance Globally?

Substance abuse treatment is becoming increasingly essential as the prevalence of substance use disorders (SUDs) continues to rise globally. Governments and healthcare systems are under pressure to provide effective treatment solutions as drug abuse, nicotine and alcohol addiction rates grow. The treatment landscape includes a variety of interventions such as medication-assisted treatment (MAT), behavioral therapies, inpatient rehabilitation, and outpatient counseling services. With the growing societal awareness of mental health and addiction issues, coupled with government initiatives to combat opioid addiction, the need for comprehensive treatment options has become critical. Moreover, the increasing cases of prescription drug misuse and the subsequent rise in addiction rates are driving the demand for advanced treatment solutions.

How Are Technological Advancements Enhancing Substance Abuse Treatment?

The integration of technology in substance abuse treatment has transformed the way care is delivered. Telemedicine and telehealth platforms are enabling remote counseling and therapy sessions, making it easier for patients to access treatment from home. Furthermore, AI-based monitoring systems are being used to track patient progress and predict the likelihood of relapse, allowing for more personalized and proactive care plans. The adoption of mobile health apps, offering self-assessment tools, counseling support, and progress tracking, has been another important development. Additionally, digital platforms are facilitating more efficient aftercare programs, which are essential for long-term recovery, reducing relapse rates and improving patient outcomes.

Which Segments Are Leading in the Substance Abuse Treatment Market?

Treatment types include medication-assisted treatment (MAT), detoxification, counseling services, and behavioral therapy, with MAT being the most widely adopted due to its effectiveness in treating opioid addiction. Patient types can be categorized into inpatient and outpatient, with outpatient treatment services seeing significant growth due to their accessibility and cost-effectiveness. Key distribution channels include hospitals, rehabilitation centers, and mental health clinics, with rehabilitation centers holding the largest market share. Geographically, North America leads the market due to the region’s opioid crisis and strong government support for addiction treatment services, while regions like Europe and Asia-Pacific are witnessing growing awareness and investment.

What Drives Growth in the Substance Abuse Treatment Market?

The growth in the Substance Abuse Treatment market is driven by several factors, including increasing addiction rates, government support for treatment programs, and technological advancements in telehealth and mobile therapy solutions. The rising focus on mental health and awareness of substance abuse-related issues is pushing healthcare providers to expand treatment services. In addition, innovations in medication-assisted treatment (MAT) and the growing adoption of digital tools for patient monitoring and aftercare management are accelerating market growth. The opioid crisis, particularly in North America, is also a significant driver of demand for substance abuse treatment services, propelling both public and private sector investments.

SCOPE OF STUDY:

The report analyzes the Substance Abuse Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Treatment (Nicotine Addiction Treatment, Alcohol Addiction Treatment, Drug Abuse Treatment)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe (France; Germany; Italy; UK; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

• Alkermes PLC
• Allergan PLC
• GlaxoSmithKline PLC
• Mallinckrodt, Inc.
• Mylan NV
• Pfizer, Inc.
• Purdue Pharma LP
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Teva Pharmaceuticals USA, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.